Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

Author: Ramsingh Giridharan   Westervelt Peter   McBride Ali   Stockerl-Goldstein Keith   Vij Ravi   Fiala Mark   Uy Geoffrey   Cashen Amanda   DiPersio John   Abboud Camille  

Publisher: Springer Publishing Company

ISSN: 0925-5710

Source: International Journal of Hematology, Vol.99, Iss.3, 2014-03, pp. : 272-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content